Suma Krishnan

CIK 1298711 · President, R&D · last filed 2026-06-05

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$454.84M

Companies

3

Total Filings

42

Lifetime Open-Market Net

-$125.35M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
KRYS President, R&D 1,430,434 $317.97 $454.84M -$124.60M 37 2026-06-05
PRECIGEN, INC. (XON) Delisted SVP--Product Development 113,314 -$745.4K 4 2016-02-01
NEW RIVER PHARMACEUTICALS INC (NRPH) Delisted Vice President, Product Dev. $0 1 2007-01-31

Recent Filings · Page 3 of 5

42 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2023-01-05 KRYS Sell (S) −7,686 -$615.5K EDGAR
2023-01-03 KRYS Sell (S) −19,422 -$1.56M EDGAR
2022-12-20 KRYS Sell (S) −21,099 -$1.69M EDGAR
2022-11-28 KRYS Sell (S) −4 -$320 EDGAR
2022-11-10 KRYS Sell (S) −1,789 -$143.2K EDGAR
2022-08-09 KRYS Sell (S) −50,000 -$4.06M EDGAR
2022-03-01 KRYS Mixed −3,282 -$205.1K EDGAR
2021-12-14 KRYS Sell (S) −100,000 -$7.05M EDGAR
2021-03-02 KRYS Grant (A) +28,400 $0 EDGAR
2020-09-17 KRYS Sell (S) −50,000 -$2.32M EDGAR
Showing 2130 of 42
Page 3 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.